Tons of things to discuss which would effectively “market” what is going on here if they wanted to. But doing so would likely offer support to the stock which would defeat the purpose.
Compassionate use demand Efficacy when used on other cancers Timeline for flaskwork implementation More detailed explanation of use for recently raised funds rather than accelerated blah blah blah
And plenty more. They initially were going to remain hush on top line data and journal publication which was going to clearly spell out the trial data in detail. Instead they have decided to hold our heads under water only to let us up every 6 months with BS (March coming soon PR was a blatant lie)
They could market the company and platform if they wanted to a heck of a lot more than a cheap tote bag. They are purposely not doing so but not to protect us. Look at what that protection is doing for us. I’d hate to see how LP treats her enemies after seeing how she treats her shareholders